The Food and Drug Administration (FDA) has announced the Commissioner’s National Priority Voucher (CNPV) Program. The idea is to have a fast-track review – as short as one to two months compared to 10 to 12 on the usual timeline – for drugs that address one or more national priorities, such as pandemic preparedness, domestic manufacturing, national security, or serious unmet medical needs.
Source: American Action Forum